No safety concerns and favourable patency at two years with ... | 合法醫療器材資訊網

The Absorb GT1 BVS System is contraindicated for use in: Patients who cannot tolerate, including allergy or hypersensitivity to, procedural anticoagulation or the​ ... Read More

2019年4月30日 — The Absorb BVS story never delivered the hoped-for happy ending. The bioresorbable scaffold first received CE Mark approval in Europe in ... Read More

2017年9月8日 — Both the Absorb and the Absorb Gt1 Bioresorbable Vascular Scaffold Systems are being discontinued. “Physicians can implant Absorb with their ... Read More

Absorb GT1™ Bioresorbable Vascular Scaffold (BVS). System. Patient Information Guide. The information contained herein does not replace the medical advice ... Read More

2018年9月27日 — 25, morphed into a discussion about the future of bioresorbable vascular scaffolds (BVS) and whether it's worth pursuing bioresorbable stent ... Read More

2020年11月9日 — The Absorb bioresorbable vascular scaffold (BVS; Abbott Vascular) can be used for the treatment of chronic limb-threatening ischaemia (CLTI) ... Read More

由 Ł Rzeszutko 著作 · 2013 · 被引用 36 次 — In 2012 BVS ABSORB™ was approved as the first biodegradable scaffold for the treatment of coronary artery disease in EU and other countries ... Read More

由 DG Rizik 著作 · 2015 · 被引用 21 次 — The advent of fully bioresorbable stent technology and specifically the ABSORB​™, a bioresorbable vascular scaffold (BVS) stent, is heralded as breakthrough ... Read More

To evaluate the safety and efficacy of the Absorb BVS System compared to the XIENCE V Everolimus Eluting Coronary Stent System (EECSS) in the treatment of ... Read More